Table 2 Three countries with the highest and lowest means of incidence, death, or DALYs
From: Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019
Measure | Top three countries | Bottom three countries | ||||
|---|---|---|---|---|---|---|
2019ASR (per 100,000 people) | ||||||
 ASIR | Monaco (14.95) | Barbados (8.57) | Dominica (7.25) | Kyrgyzstan (0.62) | Mali (0.66) | Mongolia (0.67) |
 ASDR | Monaco (9.81) | Barbados (6.17) | Dominica (5.89) | Kyrgyzstan (0.55) | Palau (0.59) | Mongolia (0.60) |
 Age Standardized DALY Rate | Monaco (199.23) | Barbados (139.63) | Dominica (132.87) | Kyrgyzstan (13.33) | Thailand (14.67) | Palau (14.71) |
Percentage change in rates from 1990 to 2019 | ||||||
 ASIR | Belarus (1.45) | Jamaica (1.24) | Estonia(1.11) | Bahrain(−0.24) | Northern Mariana Islands(− 0.23) | Guam (− 0.22) |
 ASDR | Jamaica (1.12) | Belarus (1.07) | Estonia(0.79) | Bahrain(−0.32) | Jordan(−0.28) | Northern Mariana Islands (− 0.52) |
 Age Standardized DALY Rate | Jamaica (1.18) | Belarus (1.09) | Turkmenistan (0.96) | Bahrain(−0.35) | Jordan(−0.29) | Northern Mariana Islands (− 0.26) |
1990–2019 increase cases times | ||||||
 Incidence | United Arab Emirates (9.85) | Qatar (8.39) | Djibouti (4.05) | Tokelau (−0.09) | Niue (−0.01) | Nauru (0.11) |
 Death | United Arab Emirates (8.63) | Qatar (6.63) | Djibouti(3.33) | Tokelau (−0.15) | Niue (−0.09) | Nauru (0.04) |
 DALYs | United Arab Emirates (9.35) | Qatar (6.65) | Djibouti (3.75) | Tokelau (−0.12) | Niue (−0.06) | Nauru (0.09) |